Even though radiotherapy is a therapy of first choice in the treatment of nasopharyngeal carcinoma, its radiotoxicity is often difficult to bear for patients in addition to the unsatisfactory effect in some patients. ...Even though radiotherapy is a therapy of first choice in the treatment of nasopharyngeal carcinoma, its radiotoxicity is often difficult to bear for patients in addition to the unsatisfactory effect in some patients. Therefore, an important problem in the treatment of nasopharyngeal carcinoma is to abate radiotherapeutic toxicity and improve its effect. Some progresses in promoting the effect of radiotherapy and abating its toxicity have been made through application of traditional Chinese medicine (TCM) which is briefly reviewed as follows.展开更多
目的观察芪胶升白胶囊在鼻咽癌患者同步放化疗所致骨髓抑制中的治疗作用。方法 90例同步放化疗过程中出现骨髓抑制的局部晚期鼻咽癌患者随机分为3组,实验组:芪胶升白胶囊+重组人粒细胞集落刺激因子(recombinant human granulocyte colon...目的观察芪胶升白胶囊在鼻咽癌患者同步放化疗所致骨髓抑制中的治疗作用。方法 90例同步放化疗过程中出现骨髓抑制的局部晚期鼻咽癌患者随机分为3组,实验组:芪胶升白胶囊+重组人粒细胞集落刺激因子(recombinant human granulocyte colony-stimulating factor,G-CSF);对照1组:利血生+G-CSF;对照2组:单独使用G-CSF,治疗同步放化疗所致骨髓抑制,比较其疗效及不良反应。结果治疗结束时,实验组与对照1、2组在骨髓保护方面,差异有统计学意义(P<0.05);同步放化疗结束后,及结束后1、2周,实验组较对照1、2组骨髓抑制发生率明显降低,差异均有统计学意义(P<0.05),且无不良反应。结论芪胶升白胶囊对于同步放化疗所致的白细胞下降治疗作用显著,同时可以起到较好的骨髓保护作用,且无明显不良反应,价格低廉,可作为放化疗骨髓抑制时的常规口服用药。展开更多
文摘Even though radiotherapy is a therapy of first choice in the treatment of nasopharyngeal carcinoma, its radiotoxicity is often difficult to bear for patients in addition to the unsatisfactory effect in some patients. Therefore, an important problem in the treatment of nasopharyngeal carcinoma is to abate radiotherapeutic toxicity and improve its effect. Some progresses in promoting the effect of radiotherapy and abating its toxicity have been made through application of traditional Chinese medicine (TCM) which is briefly reviewed as follows.
